Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Iowa
University of Utah
Cedars-Sinai Medical Center
Abramson Cancer Center at Penn Medicine
Baylor Research Institute
Poitiers University Hospital
University of Alabama at Birmingham
University of Oklahoma
Stony Brook University
Var2 Pharmaceuticals
Mayo Clinic
Mayo Clinic
Shanghai Juncell Therapeutics
Baylor Research Institute
UNC Lineberger Comprehensive Cancer Center
Peking Union Medical College Hospital
Icahn School of Medicine at Mount Sinai
Peking Union Medical College Hospital
KARANAHAN
Shanghai Yunying Medical Technology
Rambam Health Care Campus